AAP

EQS-News: aap receives US-American clearance (FDA) for polyaxial LOQTEQ® VA Elbow system; launch planned for Q4 2023

Retrieved on: 
Tuesday, March 21, 2023

aap receives US-American clearance (FDA) for polyaxial LOQTEQ® VA Elbow system; launch planned for Q4 2023

Key Points: 
  • aap receives US-American clearance (FDA) for polyaxial LOQTEQ® VA Elbow system; launch planned for Q4 2023
    The issuer is solely responsible for the content of this announcement.
  • aap Implantate AG (“aap”) announces that its new system LOQTEQ® VA Elbow 2.7/3.5 has been cleared by the US-American Food and Drug Administration (FDA).
  • The Company plans to launch the system LOQTEQ® VA Elbow 2.7/3.5 in the fourth quarter of 2023 in the United States and in other markets that accept FDA clearances.
  • The LOQTEQ® VA Elbow plates 2.7/3.5 belong to the LOQTEQ® VA (VA = Variable Angle) product family.

CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement

Retrieved on: 
Monday, March 20, 2023

LA JOLLA, Calif., March 20, 2023 (GLOBE NEWSWIRE) -- CalciMedica Inc. (CalciMedica) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need, today announced the closing of its previously announced merger with Graybug Vision, Inc. CalciMedica’s stock will commence trading on March 21, 2023 on the Nasdaq Global Market under the trading symbol “CALC”.

Key Points: 
  • Immediately prior to the closing of the merger, CalciMedica completed the previously announced private placement of $10.3 million.
  • “With the closing of this merger, CalciMedica enters into a pivotal new phase of its future development, and we are extremely thankful to have partnered with Graybug for this transformational deal,” said Rachel Leheny, Ph.D., Chief Executive Officer of CalciMedica.
  • Immediately following the merger, CalciMedica had approximately 5.5 million shares of common stock outstanding.
  • In connection with the merger, the parties waived the condition that the shares of Graybug Vision, Inc. common stock to be issued to CalciMedica stockholders in the merger be approved for listing on Nasdaq as of the closing of the merger.

New Data from Clay Indicates that 40% of Children Ages 3-5 Who Are Flagged with Behavioral Issues Show Signs of Anxiety

Retrieved on: 
Thursday, March 16, 2023

NEW YORK, March 16, 2023 /PRNewswire-PRWeb/ -- Clay, the behavioral health solution for early childhood education centers, today released new data from its early screening and identification platform, indicating that 40% of children ages 3-5 who were flagged with behavioral issues also showed signs of anxiety.

Key Points: 
  • Clay is an early identification platform that provides a comprehensive suite of behavioral and developmental tools for school communities that serve children ages 0-5.
  • Clay's data also indicates that there may be a strong correlation between parental anxiety and child anxiety, with up to 65% of the children flagged for behavioral issues displaying signs of anxiety when a parent also showed signs of anxiety.
  • It also signals a strong correlation between behavioral issues and developmental issues, with 51% of the children who were flagged for behavioral issues showing indications of developmental delays.
  • As this data indicates, behavioral issues often correlate with other types of mental health concerns that can and should be addressed as early as possible."

FDA Gives Greenlight for Bobbie’s First of its Kind Tolerance Formula, Expanding Product Offering and Supporting More American Babies with High-Quality, Domestically Manufactured Organic Infant Formula

Retrieved on: 
Thursday, March 16, 2023

Meet our new baby, Bobbie® Organic Gentle® -- due late Spring 2023. (Photo: Business Wire)

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20230316005244/en/
    Meet our new baby, Bobbie® Organic Gentle® -- due late Spring 2023.
  • (Photo: Business Wire)
    Bobbie has never sacrificed their commitment to high-quality, organic ingredients—and are proud to expand this promise to parents seeking a tolerance formula with partially hydrolyzed protein.
  • Bobbie’s VP of Regulatory, Christina Berberich, PharmD, MPH, RD, and Mother worked with Perrigo to bring this ideal product into existence with Bobbie’s Organic Gentle Infant Formula.
  • “We established Bobbie Labs to evolve infant feeding while shaking the formula stigma within the research community and beyond.

Nancy J. Mendelsohn, MD, FACMG, Accomplished Healthcare Leader and Medical Geneticist, is Elected President of the ACMG Foundation for Genetic and Genomic Medicine

Retrieved on: 
Thursday, March 16, 2023

BETHESDA, Md., March 16, 2023 /PRNewswire/ -- Nancy J. Mendelsohn, MD, FACMG has been elected as president of the ACMG Foundation for Genetic and Genomic Medicine.

Key Points: 
  • BETHESDA, Md., March 16, 2023 /PRNewswire/ -- Nancy J. Mendelsohn, MD, FACMG has been elected as president of the ACMG Foundation for Genetic and Genomic Medicine.
  • The ACMG Foundation is a national nonprofit foundation dedicated to improving health and patient care through the support of research, education and the safe, effective practice of genetic and genomic medicine.
  • "I am delighted that Dr. Nancy Mendelsohn will succeed me as president of the ACMG Foundation.
  • Dr. Mendelsohn is an accomplished medical geneticist with broad experience both in clinical practice and the administration and management of medical genetics services.

Honda Announces Next Steps in Preparation for U.S. EV Production

Retrieved on: 
Wednesday, March 15, 2023

This EV Hub will play a key role in developing the company?s knowledge and expertise in EV production that will be shared across Honda?s entire North American auto production network in the coming years, even as many Honda plants continue production of gasoline-powered vehicles.

Key Points: 
  • This EV Hub will play a key role in developing the company?s knowledge and expertise in EV production that will be shared across Honda?s entire North American auto production network in the coming years, even as many Honda plants continue production of gasoline-powered vehicles.
  • Each Honda auto production facility in North America will have a critical role to play in Honda?s electrification strategy.
  • This will maintain production volume of an important core model for Honda customers, while enabling MAP to transition to EV production.
  • Even as Honda accelerates preparation for EV production, the company plans to sustain current ICE and hybrid-electric vehicle production in order to continue to meet anticipated strong customer demand through 2030 and beyond.

Little Leaves Behavioral Services Announces the Opening of Its Newest Location in Frederick, Maryland

Retrieved on: 
Monday, March 13, 2023

FREDERICK, Md., March 13, 2023 (GLOBE NEWSWIRE) -- Little Leaves Behavioral Services, a leading provider of center-based behavioral health services for preschool-aged children on the autism spectrum, today announced its new location in Frederick, Maryland, is open and accepting clients.

Key Points: 
  • FREDERICK, Md., March 13, 2023 (GLOBE NEWSWIRE) -- Little Leaves Behavioral Services, a leading provider of center-based behavioral health services for preschool-aged children on the autism spectrum, today announced its new location in Frederick, Maryland, is open and accepting clients.
  • Little Leaves’ clinical staff partners with the child’s family to develop and implement individualized therapeutic plans.
  • The Frederick center joins Little Leaves’ current Maryland locations in Columbia, Germantown, Lutherville, Millersville, Silver Spring and White Marsh.
  • Little Leaves Behavioral Services is accredited by the Behavioral Health Centers of Excellence®.

New Study Reveals Infant Formula Shortages & Improved Guidance from Healthcare Associations May Have Inspired Working Parents to Breastfeed Longer

Retrieved on: 
Tuesday, March 7, 2023

Additionally, respondents shared that 31% plan to breastfeed longer in response to the new breastfeeding guidelines introduced in 2022 by the AAP.

Key Points: 
  • Additionally, respondents shared that 31% plan to breastfeed longer in response to the new breastfeeding guidelines introduced in 2022 by the AAP.
  • “Parents and families have felt the impact of the formula shortage directly and indirectly.
  • Parents are trying their best to breastfeed and pump, though the added challenge of not having enough lactation resources in the workplace is yet another barrier.
  • Paired with the changing guidance from the American Academy of Pediatrics that aligns with global public health guidance, it’s clear that babies benefit from breast milk.

Office Practicum Strengthens Leadership Team with Dr. Suzanne Berman as Medical Director of Informatics and Instruction

Retrieved on: 
Wednesday, March 1, 2023

FORT WASHINGTON, Pa., March 1, 2023 /PRNewswire/ -- Office Practicum (OP), the leading pediatric-certified EHR and practice management software provider, today announced that Suzanne Berman, MD, has been appointed Medical Director of Informatics and Instruction. With her extensive experience in pediatric medicine and industry insight, Dr. Berman will serve as the overall clinical expert for transferring knowledge to Office Practicum end users.

Key Points: 
  • FORT WASHINGTON, Pa., March 1, 2023 /PRNewswire/ -- Office Practicum (OP), the leading pediatric-certified EHR and practice management software provider, today announced that Suzanne Berman, MD, has been appointed Medical Director of Informatics and Instruction.
  • With her extensive experience in pediatric medicine and industry insight, Dr. Berman will serve as the overall clinical expert for transferring knowledge to Office Practicum end users.
  • "We are thrilled to have Dr. Berman joining us at Office Practicum as an integral member of our leadership team," said Kraig Brown, CEO of Office Practicum.
  • Dr. Berman frequently contributes to AAP projects and publications regarding medical home practice transformation, corporate compliance, rural health, coding, data mining, and policymaking.

Advance Auto Parts Reports Fourth Quarter and Full Year 2022 Results

Retrieved on: 
Tuesday, February 28, 2023

Advance Auto Parts, Inc. (NYSE: AAP), a leading automotive aftermarket parts provider in North America, that serves both professional installer and do-it-yourself customers, announced its financial results for the fourth quarter and full year ended December 31, 2022.

Key Points: 
  • Advance Auto Parts, Inc. (NYSE: AAP), a leading automotive aftermarket parts provider in North America, that serves both professional installer and do-it-yourself customers, announced its financial results for the fourth quarter and full year ended December 31, 2022.
  • Comparable store sales for the fourth quarter 2022 increased 2.1%.
  • As a percentage of Net sales, Adjusted SG&A was 38.1% in the fourth quarter, an improvement of 136 basis points from the fourth quarter of the prior year.
  • At the end of the fourth quarter of 2022, the company had $947.3 million remaining under the share repurchase program.